Kumar Dhanasekharan
With over 20 years of experience in the biopharmaceutical industry, I am an innovative leader in all aspects... | New York City Metropolitan Area, New York City Metropolitan Area, United States
*50 free lookup(s) per month.
No credit card required.
Kumar Dhanasekharan’s Emails ku****@vo****.com
Kumar Dhanasekharan’s Phone Numbers No phone number available.
Social Media
Kumar Dhanasekharan’s Location New York City Metropolitan Area, New York City Metropolitan Area, United States
Kumar Dhanasekharan’s Expertise With over 20 years of experience in the biopharmaceutical industry, I am an innovative leader in all aspects of technical operations for biologics and gene therapy products. I have expertise in process and analytical development, drug product development, manufacturing sciences, clinical manufacturing and supply, technical lifecycle planning, and regulatory CMC and quality. Currently, I am the SVP of Technical Operations at Voyager Therapeutics, a clinical-stage gene therapy company developing treatments for severe neurological diseases. I lead a team of talented scientists and engineers who are responsible for advancing our pipeline of next generation gene therapies based on adeno-associated virus (AAV) vectors. I also oversee strategic collaborations with external partners to ensure the quality, scalability, and sustainability of our products. My mission is to deliver safe and effective gene therapies to patients with unmet medical needs.
Kumar Dhanasekharan’s Current Industry Voyager Therapeutics
Kumar
Dhanasekharan’s Prior Industry
Wk Kellogg Institute For Food And Nutrition Research
|
Ansys
|
Bend Research
|
Genzyme
|
Cook Pharmica
|
Purdue University
|
Amicus Therapeutics
|
Swanbio Therapeutics
|
Renovacor
|
Voyager Therapeutics
Not the Kumar Dhanasekharan you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience
Voyager Therapeutics
SVP, Head of Technical Operations
Sun Jan 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Renovacor
Senior Vice President, Technical Operations
Fri Oct 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Dec 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Swanbio Therapeutics
Vice President, Technical Operations
Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Oct 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Amicus Therapeutics
Executive Director, Technical Development and Tech Transfer
Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Amicus Therapeutics
Senior Director and Head, Biologics Process and Analytical Development
Sat Oct 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Dec 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Purdue University
Adjunct Associate Professor
Fri Apr 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Cook Pharmica
Director of Process and Analytical Development (Biologics)
Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Oct 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Genzyme
Associate Director, Process Sciences and Technology (Biologics)
Fri Jul 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Genzyme
Principal Process Engineer/ Senior Manager
Thu May 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Jul 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Bend Research
Principal Research Engineer/ Director
Sun Jul 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Feb 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Ansys
Group Leader, Pharmaceuticals (Small and Large Molecule) and Medical Devices
Wed Sep 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Jul 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Ansys
Principal Investigator & Program Manager
Fri Feb 01 2002 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Aug 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Ansys
Engineer/ Senior Engineer
Fri Dec 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Feb 01 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Wk Kellogg Institute For Food And Nutrition Research
Post Doc. Researcher
Thu Jun 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Dec 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time)Skills
Languages
Kumar Dhanasekharan Email Addresses
FAQ About Kumar Dhanasekharan
-
Kumar Dhanasekharan is located at
New York City Metropolitan Area, New York City Metropolitan Area, United States -
Kumar Dhanasekharan is a
With over 20 years of experience in the biopharmaceutical industry, I am an innovative leader in all aspects of technical operations for biologics and gene therapy products. I have expertise in process and analytical development, drug product development, manufacturing sciences, clinical manufacturing and supply, technical lifecycle planning, and regulatory CMC and quality. Currently, I am the SVP of Technical Operations at Voyager Therapeutics, a clinical-stage gene therapy company developing treatments for severe neurological diseases. I lead a team of talented scientists and engineers who are responsible for advancing our pipeline of next generation gene therapies based on adeno-associated virus (AAV) vectors. I also oversee strategic collaborations with external partners to ensure the quality, scalability, and sustainability of our products. My mission is to deliver safe and effective gene therapies to patients with unmet medical needs. Voyager Therapeutics -
Kumar Dhanasekharan currently works in the
Voyager Therapeutics -
Kumar Dhanasekharan specializes in
With over 20 years of experience in the biopharmaceutical industry, I am an innovative leader in all aspects of technical operations for biologics and gene therapy products. I have expertise in process and analytical development, drug product development, manufacturing sciences, clinical manufacturing and supply, technical lifecycle planning, and regulatory CMC and quality. Currently, I am the SVP of Technical Operations at Voyager Therapeutics, a clinical-stage gene therapy company developing treatments for severe neurological diseases. I lead a team of talented scientists and engineers who are responsible for advancing our pipeline of next generation gene therapies based on adeno-associated virus (AAV) vectors. I also oversee strategic collaborations with external partners to ensure the quality, scalability, and sustainability of our products. My mission is to deliver safe and effective gene therapies to patients with unmet medical needs. -
Kumar Dhanasekharan speaks the following languages:
No languages available. -
Kumar Dhanasekharan has prior experience in the following industries:
Renovacor , Swanbio Therapeutics , Amicus Therapeutics , Amicus Therapeutics , Cook Pharmica , Genzyme , Genzyme , Bend Research , Ansys , Ansys , Ansys , Wk Kellogg Institute For Food And Nutrition Research -
Kumar Dhanasekharan has the following professional experience:
Voyager Therapeutics , Renovacor , Swanbio Therapeutics , Amicus Therapeutics , Amicus Therapeutics , Purdue University , Cook Pharmica , Genzyme , Genzyme , Bend Research , Ansys , Ansys , Ansys , Wk Kellogg Institute For Food And Nutrition Research . -
You can view Kumar Dhanasekharan’s
LinkedIn profile at LinkedIn URL. -
Kumar Dhanasekharan’s work email addresses are
[email protected] . -
Kumar Dhanasekharan works at
Voyager Therapeutics
People you may be interested in
- Maitha Almazrouei
- User Info Missing
- Jennifer Etheridge
- Philippa Mcevoy
- Faried Yahya
- Martin Roux
- Gary Lim
Chemical engineer
UX Lead at Tavant
Life has limitless possibilities
Head of Events Stakeholder Engagement - Priority Events Team at Department for International Trade (DIT)
Project Manager at PT. Perusahaan Gas Negara (Persero) tbk.
Leading Supply Chain Transformation Projects
AIML @ Apple